Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

Delayed Quote. Delayed  - 05/05 10:00:53 pm
105.15 USD   +1.20%
05/05 CVS HEALTH : Receives NCQA Certification in Utilization Management
05/05 CVS HEALTH : American Cancer Society and CVS Health Launch Bold Init..
05/05 CVS HEALTH : American Cancer Society and CVS Health Launch Bold Init..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

CVS Caremark 4th-Quarter Profit Rose 2.6% Amid Continued Sales Growth

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/06/2013 | 01:52pm CEST
   By Tess Stynes 
 

CVS Caremark Corp.'s (>> CVS Caremark Corporation) fourth-quarter earnings rose 2.6% as the company reported revenue growth in its pharmacy-services and retail drugstore operations.

For the year, the company raised its forecast for per-share adjusted earnings from continuing operations by two cents and now expects $3.86 to $4.

CVS's retail pharmacy business gained customers last year in the wake of a contract dispute between rival Walgreen Co.'s (>> Walgreen Company) and pharmacy-benefits manager Express Scripts Holding Co. (>> Express Scripts Holding Co) that has since been resolved.

A wave of major generic drugs introductions is having a mixed effect on the industry. Though the copycat drugs carry higher margins than branded products, they command lower prices, hurting sales revenue.

CVS Caremark reported a profit of $1.13 billion, or 90 cents a share, up from $1.1 billion, or 81 cents a share, a year earlier. Excluding debt-extinguishment losses, acquisition-related charges and other items, adjusted earnings from continuing operations were $1.14. Revenue increased 11% to $31.39 billion.

Analysts polled by Thomson Reuters most recently projected earnings of $1.10 on revenue of $31.13 billion.

Revenue in the larger pharmacy-services business climbed 17% to $18.6 billion, reflecting new client starts, higher prices and growth of its Medicare Part D program. Pharmacy network claims processed rose 6.5%.

On the retail side, revenue increased 5.1% to $16.3 billion. Same-store sales were up 4% from a year earlier, as pharmacy same-store sales also improved by 4%. Same-store sales in the front end of the store grew 3.9%.

Shares closed Tuesday at $51.72 and were inactive premarket.

Write to Tess Stynes at tess.stynes@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on CVS HEALTH CORP
05/05 CVS HEALTH : Makes Overdose-Reversal Drug Available Without A Prescription At Al..
05/05 CVS HEALTH : Receives NCQA Certification in Utilization Management
05/05 CVS HEALTH : American Cancer Society and CVS Health Launch Bold Initiative to He..
05/05 BY THE NUMBERS : Storage and Disposal of Prescription Drugs
05/05 CVS HEALTH : American Cancer Society and CVS Health Launch Bold Initiative to He..
05/05 CVS HEALTH : Experts Weigh in on Opioid Abuse Epidemic
05/04DJMcKesson Posts Higher Profit on 4% Revenue Increase
05/04DJMcKesson Posts Higher Profit on 4% Revenue Increase
05/04 CVS HEALTH : WEI Collaborates with CVS Health and Target Pharmacies
05/04 CVS HEALTH : Research Institute Study Shows that Home Infusion Care Improves Pat..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials